OVERVIEW

Scripps’ Structural Heart Intervention and Imaging conference is designed to provide a practical, cutting-edge, and live case-based assessment of structural heart disease interventions and cardiovascular imaging. The course will place a strong emphasis on the collaborative nature of these procedures across many disciplines within cardiology. Expert faculty will include interventionists, invasive cardiologists, echocardiologists, electrophysiologists, cardiothoracic surgeons, cardiac anesthesiologists, and sonographers. Faculty will discuss clinical guidelines on patient selection, pre-procedural assessment, procedural tips, techniques, and challenges (including concurrent imaging) during the performance of the procedures and conclude with assessment of outcomes and future directions.

LEARNING OBJECTIVES

After attending this live activity, participants should be able to:

• Assemble the appropriate multidisciplinary team, imaging technologies, and catheter equipment to perform structural heart disease interventions.
• Apply a comprehensive approach to the assessment of the aortic, mitral, and tricuspid valves, the interatrial septum, and the left and right ventricles, using echocardiography (TTE, TEE, and ICE), CT, and MRI for the purpose of the interventional treatment of these cardiac structures.
• Cite the current indications for LAA closure, PFO closure, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), and mitral transcatheter edge to edge repair (TEER).
• Interpret echocardiographic and CT imaging before and after LAA closure, and identify and measure peri-device leaks, device-related thrombus, and other potential complications.
• Select the appropriate treatment strategy for patients with mitral valve disease (i.e., TEER or TMVR) or tricuspid valve disease (i.e., TEER or TTVR) based upon imaging findings.
• Incorporate live TEE multiplanar imaging to optimize transcatheter mitral and tricuspid valve intervention.
• Utilize 2D and 4D ICE during structural heart intervention.
• Recognize the risk of left ventricular outflow tract obstruction after TMVR and coronary occlusion after TAVR and apply specific interventional strategies to prevent them (e.g., LAMPOON and BASILICA).
• Integrate emerging data regarding surgical risk, including low and intermediate-risk patients into TAVR decision-making.
• Identify heart failure patients who might benefit from novel interventional strategies, such as interatrial shunt devices, to improve symptoms.
• Optimize the anesthetic management of patients with reduced ejection fraction undergoing TEER or TMVR.
• Employ best practices to safely manage potential complications of catheter-based therapies for structural heart disease.

ACCREDITATION

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

Scripps Health designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page